• About
    • Mission, Vision and Values
    • Team
    • Board of Directors
    • Investors
  • Pipeline
  • VICOMER™ Platform
    • VICOMER™ Platform
    • Scientific Publications
    • Collaborators
  • News
  • Join Our Team
  • Contact Us
VICO Therapeutics
Vico Therapeutics Appoints Scott Schobel, MD as Chief Medical Officer

Vico Therapeutics Appoints Scott Schobel, MD as Chief Medical Officer

by VICO Therapeutics | Oct 3, 2022 | Management, Press Release

Dr. Schobel joins Vico from Roche where he was the clinical science leader for tominersen being developed for Huntington’s disease LEIDEN, Netherlands, October 3, 2022 – Vico Therapeutics B.V., a neurology-focused genetic medicine company, today announced the...
Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer

Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer

by VICO Therapeutics | Aug 4, 2022 | Management, Press Release

LEIDEN, Netherlands, Aug. 1, 2022 /PRNewswire/ — Vico Therapeutics B.V., a neurology-focused genetic medicine company, today announced the appointment of Micah Mackison as Chief Executive Officer. Mr. Mackison brings significant biotechnology and pharmaceutical...

© 2022 VICO Therapeutics | All rights reserved | Privacy statement


Designed and developed by Root Agency